JTC Employer Solutions Trustee Ltd Sells 1,107 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

JTC Employer Solutions Trustee Ltd lessened its position in iShares Biotechnology ETF (NASDAQ:IBB) by 50.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,107 shares of the financial services provider’s stock after selling 1,107 shares during the period. JTC Employer Solutions Trustee Ltd’s holdings in iShares Biotechnology ETF were worth $146,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth about $29,000. Highline Wealth Partners LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter worth about $30,000. Ashton Thomas Securities LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter worth about $36,000. Modus Advisors LLC acquired a new stake in iShares Biotechnology ETF in the 4th quarter worth about $41,000. Finally, Voisard Asset Management Group Inc. acquired a new stake in iShares Biotechnology ETF in the 3rd quarter worth about $59,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB traded down $0.59 during midday trading on Monday, hitting $132.14. The stock had a trading volume of 575,268 shares, compared to its average volume of 1,319,654. The company’s 50-day moving average price is $137.95 and its 200-day moving average price is $141.99. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.